Skip to Main content Skip to Navigation
Journal articles

Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine

Document type :
Journal articles
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03654311
Contributor : Guillaume Ranchon Connect in order to contact the contributor
Submitted on : Thursday, April 28, 2022 - 3:05:21 PM
Last modification on : Friday, April 29, 2022 - 3:38:24 AM

Links full text

Identifiers

Collections

Citation

Ian Pavord, Andrew Menzies-Gow, Roland Buhl, Pascal Chanez, Mark Dransfield, et al.. Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine. The Journal of Allergy and Clinical Immunology: In Practice, American Academy of Allergy, Asthma & Immunology, 2021, 9 (3), pp.1121-1132.e7. ⟨10.1016/j.jaip.2020.08.039⟩. ⟨hal-03654311⟩

Share

Metrics

Record views

0